Transfusion-related acute lung injury: Advances in understanding the role of proinflammatory mediators in its genesis

Expert Review of Hematology

Volumn 6, Issue 3, 2013, Pages 265-276

  West, F Bernadette ^a   Silliman, Christopher C ^a,b  

^a Bonfils Blood Center   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

antibodies; biologic response modifiers; neutrophils; plasma; platelet concentrates; red blood cells

Indexed keywords

AUTACOID; BIOLOGICAL RESPONSE MODIFIER; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; INTERLEUKIN 1BETA; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ARTIFICIAL VENTILATION; BLOOD COMPONENT; BLOOD STORAGE; BLOOD TRANSFUSION; DISEASE PREDISPOSITION; EXTRACORPOREAL OXYGENATION; HUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; TRANSFUSION RELATED ACUTE LUNG INJURY;

ACUTE LUNG INJURY; ANIMALS; ANTIBODIES; BLOOD TRANSFUSION; EXTRACORPOREAL MEMBRANE OXYGENATION; HLA ANTIGENS; HUMANS; INFLAMMATION MEDIATORS; NEUTROPHILS; TIME FACTORS;

EID: 84879374829     PISSN: 17474086     EISSN: 17474094     Source Type: Journal    
DOI: 10.1586/ehm.13.31     Document Type: Review

References (126)

1. Barnard RD. Indiscriminate transfusion: a critique of case reports illustrating hypersensitivity reactions. NY State J. Med. 51(20), 2399-2402 (1951).
2. Brittingham TE, Chaplin H Jr. Febrile transfusion reactions caused by sensitivity to donor leukocytes and platelets. J. Am. Med. Assoc. 165 (7), 819-825 (1957).
3. Popovsky MA, Moore SB. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 25(6), 573-577 (1985).
4. Popovsky MA, Chaplin HC Jr, Moore SB. Transfusion-related acute lung injury: a neglected, serious complication of hemotherapy. Transfusion 32(6), 589-592 (1992).
5. de Vries RR, Faber JC, Strengers PF; Board of the International Haemovigilance Network. Haemovigilance: an effective tool for improving transfusion practice. Vox Sang. 100(1), 60-67 (2011).
6. Public Health Service (PHS) Biovigilance Task Group. Biovigilance in the United States: Efforts to Bridge a Critical Gap in Patient Safety and Donor Health. US Department of Health and Human Services, Washington, DC, USA (2009).
7. Chapman CE, Stainsby D, Jones H et al.; Serious Hazards of Transfusion Steering Group. Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion 49(3), 440-452 (2009).
8. Hendrickson JE, Hillyer CD. Noninfectious serious hazards of transfusion. Anesth. Analg. 108(3), 759-769 (2009).
9. Eder AF, Herron RM Jr, Strupp A et al. Effective reduction of transfusion-related acute lung injury risk with male-predominant plasma strategy in the American Red Cross (2006-2008). Transfusion 50(8), 1732-1742 (2010).
10. Eder AF, Dy BA, Perez JM, Rambaud M, Benjamin RJ. The residual risk of transfusion-related acute lung injury at the American Red Cross (2008-2011): limitations of a predominantly male-donor plasma mitigation strategy. Transfusion doi: 10.1111/j. 1537-2995.2012.03935.x (2012) (Epub ahead of print).
11. Holness L, Knippen MA, Simmons L, Lachenbruch PA. Fatalities caused by TRALI. Transfus. Med. Rev. 18(3), 184-188 (2004).
12. Toy P, Popovsky MA, Abraham E et al.; National Heart, Lung and Blood Institute Working Group on TRALI. Transfusion-related acute lung injury: defnition and review. Crit. Care Med. 33(4), 721-726 (2005).
13. Eder AF, Herron R, Strupp A et al. Transfusion-related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross. Transfusion 47(4), 599-607 (2007).
14. US Food and Drug Administration. Fatalities Reported to FDA Following Blood Collection and Transfusion: Annual Summary for Fiscal Year 2011. US Food and Drug Administration, Silver Spring, MD, USA (2012).
15. Popovsky MA. Transfusion related acute lung injury. In: Transfusion Reactions (2nd Edition). AABB Press, MD, USA, 155-170 (2001).
16. Renaudier PC, Vo Mai MP, Azanowsky JM et al. Epidemiology of transfusion related acute lung injury in Gift, the Frech Hemovigilance Database. a study of the French Hemovigilance Network. Transfusion 44(Suppl. 9), 23A (2004).
17. Silliman CC, Paterson AJ, Dickey WO et al. The association of biologically active lipids with the development of transfusion-related acute lung injury: a retrospective study. Transfusion 37(7), 719-726 (1997).
18. Silliman CC, Boshkov LK, Mehdizadehkashi Z et al. Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood 101(2), 454-462 (2003).
19. Wallis JP, Lubenko A, Wells AW, Chapman CE. Single hospital experience of TRALI. Transfusion 43(8), 1053-1059 (2003).
20. Looney MR, Gropper MA, Matthay MA. Transfusion-related acute lung injury: a review. Chest 126(1), 249-258 (2004).
21. Middelburg RA, van Stein D, Briët E, van der Bom JG. The role of donor antibodies in the pathogenesis of transfusion-related acute lung injury: a systematic review. Transfusion 48 (10), 2167-2176 (2008).
22. Silliman CC, Fung YL, Ball JB, Khan SY. Transfusion-related acute lung injury (TRALI): current concepts and misconceptions. Blood Rev. 23(6), 245-255 (2009).
23. Vlaar AP. Transfusion-related acute lung injury: current understanding and preventive strategies. Transfus. Clin. Biol. 19(3), 117-124 (2012).
24. Benson AB, Austin GL, Berg M et al. Transfusion-related acute lung injury in ICU patients admitted with gastrointestinal bleeding. Intensive Care Med. 36(10), 1710-1717 (2010).
25. Clifford L, Singh A, Wilson GA et al. Electronic health record surveillance algorithms facilitate the detection of transfusion-related pulmonary complications. Transfusion doi:10.1111/j.1537-2995.2012.03886.x (2012) (Epub ahead of print).
26. Silliman CC. Transfusion-related acute lung injury Transfus. Med. Rev. 13(3), 177-186 (1999).
27. Cruz J, Skipworth E, Blue D, Waxman D, McCarthy L, Smith D. Transfusion-related acute lung injury: a thrombotic thrombocytopenic purpura treatment-associated case report and concise review. J. Clin. Apher. 23(2), 96-103 (2008).
28. P'ng SS, Hughes AS, Cooney JP. A case report of transfusion-related acute lung injury during plasma exchange therapy for thrombotic thrombocytopenia purpura. Ther. Apher. Dial. 12(1), 78-81 (2008).
29. Gajic O, Yilmaz M, Iscimen R et al. Transfusion from male-only versus female donors in critically ill recipients of high plasma volume components. Crit. Care Med. 35(7), 1645-1648 (2007).
30. Toy P, Gajic O, Bacchetti P et al.; TRALI Study Group. Transfusion-related acute lung injury: incidence and risk factors. Blood 119(7), 1757-1767 (2012).
31. Kleinman S, Caulfeld T, Chan P et al. Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion 44(12), 1774-1789 (2004).
32. Bux J, Sachs UJ. The pathogenesis of transfusion-related acute lung injury (TRALI). Br. J. Haematol. 136(6), 788-799 (2007).
33. Bux J. Antibody-mediated (immune) transfusion-related acute lung injury. Vox Sang. 100(1), 122-128 (2011).
34. Sachs UJ. The pathogenesis of transfusion-related acute lung injury and how to avoid this serious adverse reaction of transfusion. Transfus. Apher. Sci. 37(3), 273-282 (2007).
35. Bernard GR, Artigas A, Brigham KL et al. Report of the American-European Consensus conference on acute respiratory distress syndrome: defnitions, mecha nisms, relevant outcomes, and clinical trial coordination. Consensus Committee. J. Crit. Care 9 (1), 72-81 (1994).
36. Kuroda H, Masuda Y, Imaizumi H, Kozuka Y, Asai Y, Namiki A. Successful extracorporeal membranous oxygenation for a patient with life-threatening transfusion-related acute lung injury J. Anesth. 23(3), 424-426 (2009).
37. Lee AJ, Koyyalamudi PL, Martinez-Ruiz R. Severe transfusion-related acute lung injury managed with extracorporeal membrane oxygenation (ECMO) in an obstetric patient. J. Clin. Anesth. 20(7), 549-552 (2008).
38. Fung YL, Silliman CC. The role of neutrophils in the pathogenesis of transfusion-related acute lung injury Transfus. Med. Rev. 23(4), 266-283 (2009).
39. Albelda SM, Smith CW, Ward PA. Adhesion molecules and infammatory injury. FASEB J. 8(8), 504-512 (1994).
40. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood 84(7), 2068-2101 (1994).
41. Silliman CC. The two-event model of transfusion-related acute lung injury. Crit. Care Med. 34(Suppl. 5), S124-S131 (2006).
42. Kopko PM, Popovsky MA, MacKenzie MR, Paglieroni TG, Muto KN, Holland PV. HLA class II antibodies in transfusion-related acute lung injury. Transfusion 41(10), 1244-1248 (2001).
43. American Association of Blood Banks. AABB Standards for Blood Banks and Transfusion Services (27th Edition). American Association of Blood Banks, MD, USA (2011).
44. Vlaar A P, Kulik W, Nieuwland R et al. Accumulation of bioactive lipids during storage of blood products is not cell but plasma derived and temperature dependent. Transfusion 51(11), 2358-2366 (2011).
45. Silliman CC, Kelher M, Ambruso DR. Bioactive lipids from stored cellular blood components: in vitro method is crucial for proper interpretation. Transfusion 52 (5), 1155-1157; author reply 1157 (2012).
46. Tissot JD, Rubin O, Canellini G. Analysis and clinical relevance of microparticles from red blood cells. Curr. Opin. Hematol. 17(6), 571-577 (2010).
47. Cardo LJ, Wilder D, Salata J. Neutrophil priming, caused by cell membranes and microvesicles in packed red blood cell units, is abrogated by leukocyte depletion at collection. Transfus. Apher. Sci. 38(2), 117-125 (2008).
48. Simak J, Gelderman MP. Cell membrane microparticles in blood and blood products: potentially pathogenic agents and diagnostic markers. Transfus. Med. Rev. 20(1), 1-26 (2006).
49. Stapley R, Owusu BY, Brandon A et al. Erythrocyte storage increases rates of NO and nitrite scavenging: implications for transfusion-related toxicity. Biochem. J. 446(3), 499-508 (2012).
50. Kent MW, Kelher MR, Le T, Silliman CC. Microparticles: role in packed red blood cell (PRBC) units. Blood 120(20), 1178 (2012).
51. Bercovitz RS, Kelher MR, Khan SY, Land KJ, Berry TH, Silliman CC. The pro-infammatory effects of platelet contamination in plasma and mitigation strategies for avoidance. Vox Sang. 102(4), 345-353 (2012).
52. Tuinman PR, Gerards MC, Jongsma G, Vlaar A P, Boon L, Juffermans NP. Lack of evidence of CD40 ligand involvement in transfusion-related acute lung injury. Clin. Exp. Immunol. 165(2), 278-284 (2011).
53. Silliman CC, Voelkel NF, Allard JD et al. Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. J. Clin. Invest. 101(7), 1458-1467 (1998).
54. Van Buren NL, Stroncek DF, Clay ME, McCullough J, Dalmasso AP. Transfusion-related acute lung injury caused by an NB2 granulocyte-specifc antibody in a patient with thrombotic thrombocytopenic purpura. Transfusion 30(1), 42-45 (1990).
55. Wyman TH, Bjornsen AJ, Elzi DJ et al. A two-insult in vitro model of PMN-medi-ated pulmonary endothelial damage: requirements for adherence and chemokine release. Am. J. Physiol. Cell Physiol. 283(6), C1592-C1603 (2002).
56. Kopko PM, Marshall CS, MacKenzie MR, Holland PV, Popovsky MA. Transfusion-related acute lung injury: report of a clinical look-back investigation. JAMA 287(15), 1968-1971 (2002).
57. Toy P, Hollis-Perry KM, Jun J, Nakagawa M. Recipients of blood from a donor with multiple HLA antibodies: a lookback study of transfusion-related acute lung injury. Transfusion 44(12), 1683-1688 (2004).
58. Hashimoto S, Nakajima F, Kamada H et al. Relationship of donor HLA antibody strength to the development of transfusion-related acute lung injury. Transfusion 50(12), 2582-2591 (2010).
59. Saw CL, Hannach B, Petrazsko T, Nickerson P. Blood donors implicated in transfusion-related acute lung injury with patient-specifc HLA antibodies are more broadly sensitized to HLA antigens compared to other blood donors. Transfusion 53(3), 518-525 (2013).
60. Fung YL, Kim M, Tabuchi A et al. Recipient T lymphocytes modulate the severity of antibody-mediated transfusion-related acute lung injury. Blood 116 (16), 3073-3079 (2010).
61. Vlaar A P, Kuipers MT, Hofstra JJ et al. Mechanical ventilation and the titer of antibodies as risk factors for the development of transfusion-related lung injury. Crit. Care Res. Pract. 2012, 720950 (2012).
62. Rabinovici R, Bugelski PJ, Esser KM, Hillegass LM, Vernick J, Feuerstein G. ARDS-like lung injury produced by endotoxin in platelet-activating factor-primed rats. J. Appl. Physiol. 74 (4), 1791-1802 (1993).
63. Salzer WL, McCall CE. Primed stimulation of isolated perfused rabbit lung by endotoxin and platelet activating factor induces enhanced production of thrombox-ane and lung injury. J. Clin. Invest. 85(4), 1135-1143 (1990).
64. Kelher MR, Masuno T, Moore EE et al. Plasma from stored packed red blood cells and MHC class I antibodies causes acute lung injury in a 2-event in vivo rat model. Blood 113(9), 2079-2087 (2009).
65. Khan SY, Kelher MR, Heal JM et al. Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood 108(7), 2455-2462 (2006).
66. Looney MR, Su X, Van Ziffe JA, Lowell CA, Matthay MA. Neutrophils and their Fc J receptors are essential in a mouse model of transfusion-related acute lung injury. J. Clin. Invest. 116(6), 1615-1623 (2006).
67. Sachs UJ, Hattar K, Weissmann N et al. Antibody-induced neutrophil activation as a trigger for transfusion-related acute lung injury in an ex vivo rat lung model. Blood 107(3), 1217-1219 (2006).
68. Sachs UJ, Wasel W, Reil A et al. Mechanism of transfusion-related acute lung injury induced by HLA class II antibodies. Blood 114(22), 14 (2009).
69. Silliman CC, Moore EE, Kelher MR, Khan SY, Gellar L, Elzi DJ. Identifcation of lipids that accumulate during the routine storage of prestorage leukoreduced red blood cells and cause acute lung injury Transfusion 51(12), 2549-2554 (2011).
70. Sachs UJ. A threshold model for the susceptibility to transfusion-related acute lung injury Transfus. Clin. Biol. 19(3), 109-116 (2012).
71. Gans RO, Duurkens VA, van Zundert AA, Hoorntje SJ. Transfusion-related acute lung injury. Intensive Care Med. 14(6), 654-657 (1988).
72. Yomtovian R, Kline W, Press C et al. Severe pulmonary hypersensitivity associated with passive transfusion of a neutrophil-specifc antibody. Lancet 1(8371), 244-246 (1984).
73. Dooren MC, Ouwehand WH, Verhoeven AJ, von dem Borne AE, Kuijpers RW. Adult respiratory distress syndrome after experimental intravenous y-globulin concentrate and monocyte-reactive IgG antibodies. Lancet 352(9140), 1601-1602 (1998).
74. Silliman CC, Ambruso DR, Boshkov LK. Transfusion-related acute lung injury. Blood 105(6), 2266-2273 (2005).
75. Hidalgo A, Chang J, Jang JE, Peired AJ, Chiang EY, Frenette PS. Heterotypic interactions enabled by polarized neutro-phil microdomains mediate thromboin-fammatory injury. Nat. Med. 15 (4), 384-391 (2009).
76. Dykes A, Smallwood D, Kotsimbos T, Street A. Transfusion-related acute lung injury (TRALI) in a patient with a single lung transplant. Br. J. Haematol. 109(3), 674-676 (2000).
77. Seeger W, Schneider U, Kreusler B et al. Reproduction of transfusion-related acute lung injury in an ex vivo lung model. Blood 76 (7), 1438-1444 (1990).
78. Partrick DA, Moore EE, Fullerton DA, Barnett CC Jr, Meldrum DR, Silliman CC. Cardiopulmonary bypass renders patients at risk for multiple organ failure via early neutrophil priming and late neutrophil disability. J. Surg. Res. 86(1), 42-49 (1999).
79. Ward RA, McLeish KR. Hemodialysis with cellulose membranes primes the neutrophil oxidative burst. Artif. Organs 19 (8), 801-807 (1995).
80. Worthen GS, Schwab B 3rd, Elson EL, Downey GP. Mechanics of stimulated neutrophils: cell stiffening induces retention in capillaries. Science 245 (4914), 183-186 (1989).
81. Klein JB, McLeish KR, Ward RA. Transplantation, not dialysis, corrects azotemia-dependent priming of the neutrophil oxidative burst. Am. J. Kidney Dis. 33(3), 483-491 (1999).
82. Körmöczi GF, Rosenkranz AR, Zlabinger GJ. Polymorphonuclear granulocyte stimulation by cellulose-based hemodialysis membranes. Clin. Chem. Lab. Med. 37(3), 351-355 (1999).
83. Wallis JP, Haynes S, Stark G, Green FA, Lucas GF, Chapman CE. Transfusion-related alloimmune neutropenia: an unde-scribed complication of blood transfusion. Lancet 360(9339), 1073-1074 (2002).
84. Varela M, Mas A, Nogués N, Escorsell A, Mazzara R, Lozano M. TRALI associated with HLA class II antibodies. Transfusion 42(8), 1102 (2002).
85. Win N, Brown C, Navarrete C. TRALI associated with HLA class II antibodies. Transfusion 43(4), 545-546 (2003).
86. Gajic O, Rana R, Winters JL et al. Transfusion related acute lung injury in the critically Ill: prospective nested case-con-trol study. Am. J. Respir. Crit Care Med. 176(9), 886-891 (2007).
87. Kopko PM, Paglieroni TG, Popovsky MA, Muto KN, MacKenzie MR, Holland PV. TRALI: correlation of antigen-antibody and monocyte activation in donor-recipient pairs. Transfusion 43(2), 177-184 (2003).
88. Kelher MR, Silliman CC. Antibodies specifc for MHC class II antigens cause TRALI directly in a two-event in vivo model. Blood 120, 845 (2012).
89. Wang D, Sun J, Solomon SB, Klein HG, Natanson C. Transfusion of older stored blood and risk of death: a meta-analysis. Transfusion 52 (6), 1184-1195 (2012).
90. van de Watering L. Pitfalls in the current published observational literature on the effects of red blood cell storage. Transfusion 51(8), 1847-1854 (2011).
91. van de Watering L, Lorinser J, Versteegh M, Westendord R, Brand A. Effects of storage time of red blood cell transfusions on the prognosis of coronary artery bypass graft patients. Transfusion 46 (10), 1712-1718 (2006).
92. Kor DJ, Kashyap R, Weiskopf RB et al. Fresh red blood cell transfusion and short-term pulmonary, immunologic, and coagulation status: a randomized clinical trial. Am. J. Respir. Crit. Care Med. 185(8), 842-850 (2012).
93. Middelburg RA, Borkent-Raven BA, Borkent B et al. Storage time of blood products and transfusion-related acute lung injury. Transfusion 52(3), 658-667 (2012).
94. Vlaar AP, Hofstra JJ, Kulik W et al. Supernatant of stored platelets causes lung infammation and coagulopathy in a novel in vivo transfusion model. Blood 116 (8), 1360-1368 (2010).
95. Vlaar AP, Binnekade JM, Prins D et al. Risk factors and outcome of transfusion-related acute lung injury in the critically ill: a nested case-control study. Crit. Care Med. 38(3), 771-778 (2010).
96. Silliman CC, Dickey WO, Paterson AJ et al. Analysis of the priming activity of lipids generated during routine storage of platelet concentrates. Transfusion 36(2), 133-139 (1996).
97. Silliman CC, Clay KL, Thurman GW, Johnson CA, Ambruso DR. Partial characterization of lipids that develop during the routine storage of blood and prime the neutrophil NADPH oxidase. J. Lab. Clin. Med. 124(5), 684-694 (1994).
98. Silliman CC, Khan SY, Ball JB, Kelher MR, Marschner S. Mirasol pathogen reduction technology treatment does not affect acute lung injury in a two-event in vivo model caused by stored blood components. Vox Sang. 98(4), 525-530 (2010).
99. Dzieciatkowska M, Silliman CC, Moore EE et al. Proteomic analysis of the supernatant of red blood cell units: the effects of storage and leukoreduction. Vox Sang. (2013) (In Press).
100. Khan SY, McLaughlin NJ, Kelher MR et al. Lysophosphatidylcholines activate G2A inducing G(cti)-/G((Xq/)-Ca(2)(+) fux, G(ßy)-Hck activation and clathrin/ß-arrestin-1/GRK6 recruitment in PMNs. Biochem. J. 432(1), 35-45 (2010).
101. Silliman CC, Bjornsen AJ, Wyman TH et al. Plasma and lipids from stored platelets cause acute lung injury in an animal model. Transfusion 43(5), 633-640 (2003).
102. Looney MR, Nguyen JX, Hu Y, Van Ziffe JA, Lowell CA, Matthay MA. Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injury J. Clin. Invest. 119(11), 3450-3461 (2009).
103. Bayat B, Tjahjono Y, Akylbek S et al. Lung endothelial injury induced by HNA-3a antibodies in TRALI. Blood 120(20), 22 (2012).
104. Vlaar AP, Hofstra JJ, Determann RM et al. Transfusion-related acute lung injury in cardiac surgery patients is characterized by pulmonary infammation and coagulopathy: a prospective nested case-control study. Crit. Care Med. 40(10), 2813-2820 (2012).
105. Covin RB, Ambruso DR, England KM et al. Hypotension and acute pulmonary insuffciency following transfusion of autologous red blood cells during surgery: a case report and review of the literature. Transfus. Med. 14(5), 375-383 (2004).
106. Tuinman PR, Schultz MJ, Juffermans NP. Coagulopathy as a therapeutic target for TRALI: rationale and possible sites of action. Curr. Pharm. Des. 18(22), 3267-3272 (2012).
107. Vlaar AP, Hofstra JJ, Levi M et al. Supernatant of aged erythrocytes causes lung infammation and coagulopathy in a 'two-hit' in vivo syngeneic transfusion model. Anesthesiology 113(1), 92-103 (2010).
108. Blumberg N, Heal JM, Gettings KF et al. An association between decreased cardiopulmonary complications (transfusion-related acute lung injury and transfusion-associated circulatory overload) and implementation of universal leukore-duction of blood transfusions. Transfusion 50(12), 2738-2744 (2010).
109. Silliman CC, Moore EE, Johnson JL, Gonzalez RJ, Biff WL. Transfusion of the injured patient: proceed with caution. Shock 21(4), 291-299 (2004).
110. Insunza A, Romon I, Gonzalez-Ponte ML et al. Implementation of a strategy to prevent TRALI in a regional blood centre. Transfus. Med. 14(2), 157-164 (2004).
111. Endres RO, Kleinman SH, Carrick DM et al.; National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Study-II. Identifcation of specifcities of antibodies against human leukocyte antigens in blood donors. Transfusion 50 (8), 1749-1760 (2010).
112. Kleinman SH, Triulzi DJ, Murphy EL et al.; National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Study-II. The Leukocyte Antibody Prevalence Study-II (LAPS-II): a retrospective cohort study of transfusion-related acute lung injury in recipients of high-plasma-volume human leukocyte antigen antibody-positive or-negative com ponents. Transfusion 51(10), 2078-2091 (2011).
113. Curtis BR. Future preventive and therapeutic targets for transfusion-related acute lung injury. Curr. Pharm. Des. 18(22), 3285-3292 (2012).
114. Makar RS, Powers A, Stowell CP. Reducing transfusion-related acute lung injury risk: evidence for and approaches to transfusion-related acute lung injury mitigation. Transfus. Med. Rev. 26(4), 305-320 (2012).
115. Gilliss BM, Looney MR, Gropper MA. Reducing noninfectious risks of blood transfusion. Anesthesiology 115(3), 635-649 (2011).
116. Middelburg RA, Van Stein D, Zupanska B et al. Female donors and transfusion-related acute lung injury: a case-referent study from the International TRALI Unisex Research Group. Transfusion 50(11), 2447-2454 (2010).
117. Hellstern P, Solheim BG. The use of solvent/detergent treatment in pathogen reduction of plasma. Transfus. Med. Hemother. 38(1), 65-70 (2011).
118. Fuggle SV, Martin S. Tools for human leukocyte antigen antibody detection and their application to transplanting sensitized patients. Transplantation 86(3), 384-390 (2008).
119. Zeevi A, Girnita A, Duquesnoy R. HLA antibody analysis: sensitivity, specifcity, and clinical signifcance in solid organ transplantation. Immunol. Res. 36(1-3), 255-264 (2006).
120. Bierling P, Bux J, Curtis B et al. Recommendations of the ISBT Working Party on Granulocyte Immunobiology for leucocyte antibody screening in the investigation and prevention of antibody-mediated transfusion-related acute lung injury. Vox Sang. 96(3), 266-269 (2009).
121. Sachs UJ, Bux J. TRALI after the transfusion of cross-match-positive granulocytes. Transfusion 43(12), 1683-1686 (2003).
122. Bux J. Challenges in the determination of clinically signifcant granulocyte antibodies and antigens. Transfus. Med. Rev. 10(3), 222-232 (1996).
123. Fung YL, Goodison KA, Wong JK, Minchinton RM. Investigating transfusion-related acute lung injury (TRALI). Intern. Med. J. 33(7), 286-290 (2003).
124. Schmidt EP, Yang Y, Janssen WJ et al. The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis. Nat. Med. doi:10.1038/nm.2843 (2012) (Epub ahead of print).
125. Giarratana MC, Rouard H, Dumont A et al. Proof of principle for transfusion of in vitro-generated red blood cells. Blood 118 (19), 5071-5079 (2011).
126. Silliman CC, Kelher MR, Khan SY, Sowemimo-Coker SO. Experimental antibody fltration inhibits antibody-mediated neutrophil priming and TRALI in an in vivo model. Blood 118(21), 22 (2011).